Leuprolide 3.75 on day 18 then how it affect menstrual flow8

Reading File

Finding Sources

Reading File

Finding Sources

Searching the Web

leuprolide 3.75mg given day 18 of cycle effect on menstrual flow next period

Here is a complete, clinically structured answer:

Leuprolide 3.75 mg (Depot) Given on Day 18 - Effect on Menstrual Flow

Understanding Day 18 of the Cycle

Day 18 falls in the mid-to-late luteal phase (after ovulation has already occurred, assuming a standard 28-day cycle). At this point:

The corpus luteum is actively secreting progesterone and estrogen
Ovulation has already taken place
The endometrium is in its secretory (luteal) phase

Phase 1: Initial Flare Effect (Days 1-7 after injection)

When leuprolide is first given, it acts as a GnRH agonist - it initially stimulates the pituitary to release a surge of LH and FSH. However, on day 18, ovulation has already occurred, so this flare has less clinical impact on ovulation itself. The surge may:

Slightly prolong the luteal phase by temporarily sustaining the corpus luteum
Cause mild breast tenderness or bloating transiently

Phase 2: Pituitary Down-Regulation (Days 7-14 after injection)

Continuous, non-pulsatile GnRH receptor stimulation from the depot causes down-regulation and desensitization of pituitary GnRH receptors. FSH and LH levels fall sharply. This leads to:

Luteolysis (corpus luteum fails) - progesterone drops
Withdrawal bleeding occurs - this is the expected next "period", usually within 1-2 weeks after the injection
This bleed is often described as a heavier or irregular flow compared to a normal period - it may come slightly later than expected (within ~2 weeks) as the progesterone withdrawal triggers it

Phase 3: Sustained Ovarian Suppression - Amenorrhea

After that withdrawal bleed, with continued depot action (3.75 mg lasts ~4 weeks):

FSH and LH remain suppressed - no new follicular recruitment
Estrogen falls to menopausal/hypogonadal levels (typically <20-30 pg/mL)
No new ovulation occurs
Amenorrhea develops - menstrual periods stop within 1-2 months of starting treatment

According to the Lupron Depot prescribing data, menses are considered suppressed when no menstrual-like bleeding occurs for more than 60 days. Most patients on monthly 3.75 mg depot achieve amenorrhea by the 2nd month.

Summary Timeline

Time After Injection	What Happens to Menstrual Flow
Days 1-7	GnRH flare; no immediate bleeding change; luteal phase continues
Days 7-14	Progesterone falls (corpus luteum regresses); withdrawal bleed - the last "period"
Week 3-4	No new follicle development; ovarian suppression deepens
Month 2 onward	Amenorrhea - periods stop completely

Clinical Notes

The withdrawal bleed after day-18 injection is normal and expected - not a treatment failure
If the drug is given in the early follicular phase (days 1-5), it can suppress that cycle and delay the next period differently; day 18 administration typically still allows one withdrawal bleed first
Amenorrhea reversal: periods usually return within 3 months after stopping leuprolide depot (per drugs.com)
Breakthrough or irregular spotting can occur early in treatment and is not uncommon

Bottom line: Leuprolide 3.75 mg given on day 18 will most likely allow the current cycle to complete with a slightly delayed or normal withdrawal bleed (within ~10-14 days), followed by progressive amenorrhea as ovarian suppression takes hold. - Katzung's Basic and Clinical Pharmacology, 16th Ed.

Day first of period is 12 julyPeriod cycle is 22 days , 1st day of period is 12 july and leuprolide 3.75 is given on 30 july and period comes on 7 August, the period flow is very less why

Finding Sources

Searching the Web

leuprolide 3.75 depot luteal phase injection light period scanty flow reason mechanism

This is an excellent clinical question. Let me break this down precisely.

Exact Timeline Analysis

Date	Day of Cycle	Event
12 July	Day 1	Period starts (cycle = 22 days)
~22 July	Day 11	Ovulation (in a 22-day cycle, ovulation ~Day 11)
30 July	Day 19	Leuprolide 3.75 mg depot injected
3 August	Day 22 (expected)	Period was due here
7 August	Day 26	Period actually arrived - 4 days late, very light flow

Why the Period Came Late and Was Very Light - Step by Step

1. Leuprolide Given on Day 19 = Mid-Late Luteal Phase

On Day 19 of a 22-day cycle, the corpus luteum is already active and progesterone is at its peak. The injection caused an initial GnRH flare, which temporarily raised LH and FSH, slightly prolonging corpus luteum function - this explains why the period came 4 days late instead of on Day 22 (3 August).

2. The Key Reason for Scanty Flow - Rapid Estrogen Suppression

This is the most important mechanism:

Normally, estrogen builds the endometrial lining during the follicular phase. But leuprolide was injected on Day 19, and by the time the corpus luteum regressed (~Day 24-26), the drug had already started suppressing estrogen production.

The result:

The endometrium could not proliferate properly after progesterone withdrawal, because the falling estrogen blocked re-estrogenization
There was very little lining to shed - hence scanty/light flow
This is a pharmacological hypomenorrhea - not a pathological finding

According to the FDA labeling for Lupron Depot 3.75 mg:

"Most of the remaining patients reported episodes of only light bleeding or spotting" in the first treatment month.

3. The Endometrium Was Already in Secretory Phase

Since the injection was given in the late luteal phase, the endometrium was already in its secretory (post-ovulatory) phase - not building further. There was no new estrogen-driven proliferation happening. When the corpus luteum failed (progesterone dropped), the lining that shed was:

Thin (secretory endometrium, not a thick proliferative one)
Poorly vascularized due to falling estrogen
Result = very light, scanty period

Summary: Why the Flow Was Very Less

Mechanism	Effect
Leuprolide suppresses FSH/LH within 7-10 days	Estrogen production drops rapidly
Injected in late luteal phase - no new follicular growth	No estrogen to thicken the lining
Endometrium was already in secretory phase	Very little tissue to shed
Initial flare delayed progesterone withdrawal	Period came 4 days late
Hypo-estrogenic state develops fast	Endometrial atrophy begins immediately

Is This Normal?

Yes, this is completely expected and normal. The FDA data confirms:

74% of women on Lupron Depot 3.75 mg achieved full amenorrhea after the first month
Most of the remaining 26% had only light bleeding or spotting

This light period on 7 August is likely the last period this patient will have for the duration of treatment. From next month onward, amenorrhea is expected as ovarian suppression becomes complete.

Bottom line: The scanty flow on 7 August is a direct pharmacological effect - leuprolide rapidly suppressed estrogen, leaving an atrophic, underprepared endometrium with very little tissue to shed. This is expected and reassuring that the drug is working. - Katzung's Basic and Clinical Pharmacology, 16th Ed. & Lupron Depot FDA label

Patient have going to frozen embryo transfer this cycle ,does this affect

Reading File

Finding Sources

Searching the Web

leuprolide GnRH agonist down regulation frozen embryo transfer FET protocol endometrial preparation

Finding Sources

Searching the Web

thin endometrium after leuprolide GnRH agonist FET can embryo transfer proceed endometrial thickness minimum

Excellent - I now have comprehensive information. Here is the full clinical answer:

Does Leuprolide 3.75 mg Affect This FET Cycle?

Short answer: YES - significantly. But whether it helps or harms depends entirely on which FET protocol is being used.

Understanding the Two FET Protocol Options

Protocol A: Natural Cycle FET (NC-FET)

The embryo is transferred based on natural ovulation, using the body's own hormones.

Impact of leuprolide here: MAJOR PROBLEM

Leuprolide suppresses LH and FSH → no dominant follicle will develop
No ovulation will occur this cycle
Natural cycle FET cannot proceed because there is no natural ovulatory event to anchor embryo transfer timing
The scanty period on 7 August confirms ovarian suppression has already begun

Protocol B: Hormone Replacement Therapy (HRT-FET / Artificial Cycle FET)

Exogenous estrogen is given to thicken the endometrium, then progesterone is added to trigger secretory transformation, and the embryo is transferred at a calculated time.

Impact of leuprolide here: This is actually the INTENDED setup - leuprolide IS part of the protocol

The Leuprolide-Downregulation FET Protocol (Standard Practice)

This is in fact one of the most widely used FET protocols globally. The standard sequence is:

Step	What Happens
Leuprolide 3.75 mg given (late luteal/mid-cycle)	Pituitary down-regulation begins
Scanty period arrives (7 August - ✅ this already happened)	Confirms down-regulation is working
Day 2-3 of this bleed (9-10 August)	Start exogenous estradiol valerate (typically 2-6 mg/day orally)
Day ~12-14	Ultrasound check - endometrial thickness target ≥8 mm, trilaminar pattern
When endometrium ready	Start progesterone (vaginal/IM) for 3-5 days
Day 3-5 of progesterone (depending on embryo stage)	Embryo transfer

Per Frontiers in Medicine 2024, the GnRH agonist + HRT protocol has shown positive therapeutic effects particularly for patients with thin endometrium or adenomyosis and in recurrent implantation failure.

The Critical Concern: Endometrial Thickness

This is the main worry with the current situation:

Leuprolide suppresses estrogen → endometrium became thin (explaining the scanty period)
For FET to succeed, the endometrium must reach ≥7-8 mm with a trilaminar (triple-line) pattern before progesterone is started
Studies confirm clinical pregnancy and live birth rates drop significantly below 7 mm and are optimal at 9-14 mm (Canadian ART Registry data, 20,114 FET cycles)

The good news: The thin endometrium caused by leuprolide is reversible and correctable - exogenous estradiol given now will rebuild it. This is the entire purpose of the HRT-FET protocol.

What Needs to Happen Now (Action Points)

Do NOT attempt natural cycle FET - it won't work; ovulation is suppressed
Start estradiol valerate (oral/transdermal) from Day 2-3 of the current bleed (9-10 August) - this rebuilds the endometrium under pituitary suppression by leuprolide
Monitor endometrial thickness by ultrasound around Day 12-14 (approximately 20-22 August)
Only add progesterone and proceed to transfer when endometrium ≥8 mm with trilaminar pattern
If endometrium does not reach 8 mm with standard estradiol dose, consider increasing estradiol dose or adding vaginal estrogen

Summary

Concern	Answer
Can FET happen this cycle?	Yes, but only as an HRT-FET (artificial cycle), not natural cycle
Is the scanty period a problem?	No - it confirms down-regulation worked; this is expected
Does leuprolide harm embryo quality?	No - it does not affect the frozen embryo itself
Does it affect endometrium?	Yes - it suppresses estrogen, causing thin lining; must be corrected with exogenous estradiol
Will FET success rate be affected?	Not if endometrium reaches ≥8 mm before transfer; outcome depends on adequate estradiol response
Biggest risk?	Proceeding to transfer with endometrium <7 mm = low implantation rate

The leuprolide given on 30 July has effectively set up a pituitary down-regulated HRT-FET cycle - this is actually a standard and well-validated approach. The key next step is starting exogenous estradiol now (Day 2 of August 7 bleed) and confirming adequate endometrial development before progesterone is added.

Explain leuprolide downregulation fet protocol for fet transfer from my cycle with date

Finding Sources

Searching the Web

leuprolide downregulation HRT FET protocol step by step estradiol valerate days progesterone transfer timing blastocyst cleavage

I now have everything needed to map out the full protocol with exact dates. Here it is:

Leuprolide Down-Regulation FET Protocol - Your Patient's Calendar

What Has Already Happened ✅

Date	Event	Status
12 July	Period Day 1 (previous cycle)	✅ Done
30 July (Day 19)	Leuprolide 3.75 mg depot injected	✅ Done
7 August	Withdrawal bleed / Period Day 1 of FET cycle	✅ Done - confirms down-regulation working

What Happens Now - Step by Step with Dates

STEP 1: Baseline Scan

📅 9 August (Day 2 of bleed) or 10 August (Day 3)

Before starting estrogen, a transvaginal ultrasound is done to confirm:

Endometrial thickness <5 mm (suppressed) ✅ expected given leuprolide
Progesterone level <1.0 ng/mL (confirms down-regulation)
No ovarian cysts
No follicular activity

If confirmed - green light to start estrogen.

STEP 2: Start Estradiol Valerate (Endometrial Building Phase)

📅 Start: 9 or 10 August (Day 2-3 of FET cycle bleed)

Estradiol valerate 4-8 mg/day orally (e.g., Progynova / Estrofem)
Purpose: rebuild the suppressed, thin endometrium
This phase lasts ~10-14 days
Typical dose titration: start 4-6 mg/day; increase to 8 mg/day if lining grows slowly

STEP 3: First Monitoring Ultrasound

📅 ~19-21 August (Day 10-12 of estrogen)

Transvaginal scan checks:

Endometrial thickness - target ≥8 mm, ideally 9-12 mm
Endometrial pattern - must be trilaminar (triple line) 📐
Serum estradiol level
Confirm no spontaneous follicular growth (pituitary still suppressed by leuprolide)

Three possible outcomes:

Finding	Action
Endometrium ≥8 mm, trilaminar	Proceed - start progesterone
Endometrium 6-7 mm	Increase estradiol dose; re-scan in 4-5 days
Endometrium <6 mm (thin)	Escalate dose, consider adding vaginal estrogen; may need to postpone

STEP 4: Start Progesterone (Endometrial Transformation)

📅 ~21-22 August (once endometrium confirmed ≥8 mm)

This is the most critical timing step. Once progesterone starts, the "window of implantation" clock begins.

Options:

Vaginal progesterone gel (Crinone 8%, 90 mg once daily) OR
Micronized vaginal progesterone (Utrogestan 200-400 mg twice daily) OR
Progesterone in oil IM (50-100 mg/day)
Continue estradiol at same dose throughout

STEP 5: Embryo Transfer Day

📅 Depends on embryo stage:

Embryo Type	Days of Progesterone Before Transfer	Transfer Date (approx.)
Cleavage stage (Day 3 embryo)	4 days after starting progesterone	~25 August
Blastocyst (Day 5 embryo)	6 days after starting progesterone	~27-28 August

This is because the embryo must be synchronized with the endometrium - the endometrium must be in its Day 4 or Day 6 secretory phase to match a Day 3 or Day 5 embryo respectively.

STEP 6: Luteal Support (Continue After Transfer)

📅 From transfer day until pregnancy test and beyond

Continue estradiol valerate (same dose)
Continue progesterone (same dose and route)
Leuprolide depot is not continued (it has served its purpose)

STEP 7: Pregnancy Test (Beta-hCG)

📅 ~10-12 days after embryo transfer

If blastocyst transfer ~27 August → Beta hCG on ~7-8 September
If Day 3 cleavage transfer ~25 August → Beta hCG on ~5-6 September

Full Calendar Summary

JULY
30 July       → Leuprolide 3.75 mg injected ✅

AUGUST
7 August      → Period / Day 1 of FET cycle ✅
8 August      → TODAY
9-10 August   → Baseline scan + start ESTRADIOL VALERATE (4-8 mg/day)
19-21 August  → Monitoring scan (check endometrial thickness ≥8 mm)
21-22 August  → Start PROGESTERONE (if lining ready)
25 August     → Transfer (if Day 3 cleavage embryo)
27-28 August  → Transfer (if Day 5 blastocyst)
5-8 September → BETA hCG pregnancy test

Key Points to Remember

Point	Detail
The leuprolide has done its job	No need for another injection
Start estrogen TODAY or tomorrow	Do not delay - window is Day 2-3 of bleed
The thin/scanty period was expected	It confirms pituitary suppression worked
Transfer only if endometrium ≥8 mm	Never transfer on thin lining - low success
Trilaminar pattern is mandatory	Confirms proper estrogenic response
Progesterone timing is critical	This synchronizes embryo and endometrium

Per PMC literature on GnRHa-HRT FET protocols and Springer reproductive medicine data, this protocol has shown higher clinical pregnancy rates and live birth rates compared to natural cycle FET, particularly in patients who have had prior implantation issues.

This is a shared conversation. Sign in to Orris to start your own chat.